# Abbott Laboratories (ABT) — Q4-2013 Earnings Results

**Report date:** 2014-01-22 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2013

## Post-Earnings Brief

### Headline

Abbott Labs Misses on EPS, Stock Down 2.68%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | N/A | -0.17% |

### Management Commentary

**Tone:** Defensive

Management expressed caution regarding market conditions and highlighted the importance of maintaining operational efficiency. They did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management noted challenges in the current market environment.

> They emphasized a focus on cost management and efficiency.

> Future growth will depend on strategic investments and product innovation.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported earnings that fell short of expectations, leading to a decline in stock price by 2.68%. The company is facing challenges in the market, which has made management cautious about future performance. Without specific guidance, investors may be uncertain about the company's direction in the coming quarters.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2013_